This Kings College manufacturing facility are things we should not have to look for. I came away from the most recent 10Q wondering about the progress at Sawston. The remediation statement was about the same we have seen so progress just seemed slow there.
Fraunhofer had been supplying test materials to the UK based on past detective work by some posters. Another piece of info that investors needed to search for. So you would start to wonder if NWBO was going to really commercially move forward where would product come from for something like PIM.
Who would know the start in the UK would come from a new facility at Kings College. Looking at the number this small facility would start to do over $15 million (final patient cost) per annum if I assume 80% margin. That looks to calm my fears that they can start to manufacture commercially in the UK prior to Sawston booting up.
So the person who first found this I commend you for great DD. For NWBO management, why make us have to find all this stuff! As an investor you need to be willing to participate in a scavenger hunt to stay invested.
News 
Market Data 
Discover 
AI
